Deutsche Takes A Look At Johnson & Johnson's Patent Woes By: Benzinga via Benzinga August 18, 2016 at 14:53 PM EDT Deutsche Bank maintained its Buy rating on Johnson & Johnson (NYSE: JNJ) despite a federal judge invalidated the company's ... Read More >> Related Stocks: Johnson & Johnson Pfizer